ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Capital expenditures 2018–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$686,000FY2025 · since FY2018: $0 → $686,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $686,000 | +379.7% |
| FY2024 | $143,000 | -66.6% |
| FY2023 | $428,000 | +28.5% |
| FY2022 | $333,000 | -66.5% |
| FY2021 | $995,000 | +210.0% |
| FY2020 | $321,000 | +8.8% |
| FY2019 | $295,000 | — |
| FY2018 | $0 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice